Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
JCI Insight - Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6–deficient process
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia | Leukemia
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia | Leukemia
Pathology Outlines - CD38
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Cells | Free Full-Text | The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia | SpringerLink
Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia | PLOS ONE
Prognostic Factors
Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia | PLOS ONE
Representative flow cytometry profiles of CD38 expression in patients... | Download Scientific Diagram
Representative flow cytometric profiles of CD38 expression on mutated... | Download Scientific Diagram
Prognostic markers in chronic lymphocytic leukemia | Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
The role of CD38 expression on NAD levels and cell physiology in a leukaemia model | Semantic Scholar
Pathology Outlines - CD38
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia - ScienceDirect
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project - Rawstron - 2018 - Cytometry
The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia Hendy OM, El Shafie MA, Allam MM, Motalib TA, Khalaf FA, Gohar SF - Egypt J Haematol
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule | Molecular Medicine | Full Text
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia - ScienceDirect
Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4 | Haematologica
